Bildik, Gamze <br/><br/>
Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.  [electronic resource] 

 -  Cell death & disease  04 2018 
 - 421 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/s41419-018-0459-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetonitriles--pharmacology<br/>Animals<br/>Anthracenes--pharmacology<br/>Anti-Mullerian Hormone--blood<br/>Apoptosis--drug effects<br/>Benzothiazoles--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Estradiol--metabolism<br/>Female<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Granulosa Cell Tumor--drug therapy<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Mice<br/>Mice, SCID<br/>Mitosis<br/>Ovarian Neoplasms--drug therapy<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Signal Transduction--drug effects